Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans

Microbiology

Volumn 145, Issue 8, 1999, Pages 1989-2000

  Arndt, Cristl ^a   Cruz, Maria Cristina ^a   Cardenas, Maria E ^a   Heitman, Joseph ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FK506 FK520; Growth inhibition; Immunosuppression; rapamycin; Streptomyces

Indexed keywords

ASCOMYCIN; BACTERIAL TOXIN; CALCINEURIN; FK 506 BINDING PROTEIN; RAPAMYCIN; TACROLIMUS;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE; FUNGUS GROWTH; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STREPTOMYCES HYGROSCOPICUS;

CRYPTOCOCCUS NEOFORMANS; SACCHAROMYCES CEREVISIAE; STREPTOMYCES; STREPTOMYCES HYGROSCOPICUS;

EID: 0032841468     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-145-8-1989     Document Type: Article

References (65)

1. Abraham, R. T. & Wiederrecht, G. J. (1996). Immunopharmacology of rapamycin. Annu Rev Immunol 14, 483-510.
2. Alarcon, C. M., Cardenas, M. E. & Heitman, J. (1996). Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast. Genes Dev 10, 279-288.
3. Aparicio, J. F., Molnár, I., Schwecke, T., König, A., Haydock, S. F., Khaw, L. E., Staunton, J. & Leadlay, P. F. (1996). Organization of the biosynthetic gene cluster for rapamycin in Streptomyces hygroscopicus: analysis of the enzymatic domains in the modular polyketide synthase. Gene 169, 9-16.
4. Baker, H., Sidorowicz, A., Sehgal, S. N. & Venzina, C. (1978). Rapamycin (AY-22,989), a new antifungal antibiotic. III. In vitro and in vivo evaluation. J Antibiot 31, 539-545.
5. Barbet N. C., Schneider, U., Helliwell, S. B., Stansfield, I., Tuite, M. F. & Hall, M. N. (1996). TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 7, 25-42.
6. Bram, R. J., Hung, D. T., Martin, P. K., Schreiber, S. L. & Crabtree, G. R. (1993). Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol Cell Biol 13, 4760-4769.
7. Breuder, T., Hemenway, C. S., Movva, N. R., Cardenas, M. E. & Heitman, J. (1994). Calcineurin is essential in cyclosporin A-and FK506-sensitive yeast strains. Proc Natl Acad Sci USA 91, 5372-5376.
8. Brown, E. J., Albers, M. W., Shin, T. B., Ichikawa, K., Keith, C. T., Lane, W. S. & Schreiber, S. L. (1994). A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-759.
9. Brunn, G. J., Hudson, C. C., Sekulic, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., Jr & Abraham, R. T. (1997). Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277, 99-101.
10. Cafferkey, R., Young, P. R., McLaughlin, M. M. & 7 other authors (1993). Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol 13, 6012-6023.
11. Cardenas, M. E., Hemenway, C., Muir, R. S., Ye, R., Florentino, D. & Heitman, J. (1994). Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands. EMBO J 13, 5944-5957.
12. Cardenas, M. E., Zhu, D. & Heitman, J. (1995a). Molecular mechanisms of immunosuppression by cyclosporin, FK506, and rapamycin. Curr Opin Nephrol Hypertens 4, 472-477.
13. Cardenas, M. E., Muir, R. S., Breuder, T. & Heitman, J. (1995b). Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. EMBO J 14, 2772-2783.
14. Chadwick, D. J. & Whelan, J. (1992). Secondary Metabolites: Their Function and Evolution. New York : Wiley.
15. Chiu, M. I., Katz, H. & Berlin, V. (1994). RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc Natl Acad Sci USA 91, 12574-12578.
16. di Como, C. J. & Arndt, K. T. (1996). Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev 10, 1904-1916.
17. Cortes, J., Haydock, S. H., Roberts, G. A., Bevitt, D. J. & Leadlay, P. F. (1990). An unusually large multifunctional polypeptide in the erythromycin producing polyketide synthase of Saccharopolyspora erythraea. Nature 348, 176-178.
18. Cruz, M. C., Cavallo, L. M., Görlach, J., M., Cox, G., Perfect, J. R., Cardenas, M. E. & Heitman, J. (1999). Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol Cell Biol 19, 4101-4112.
19. Donadio, S., Staver, M. J., McAlpine, J. B., Swanson, S. J. & Katz, L. (1991). Modular organization of genes required for complex polyketide biosynthesis. Science 252, 675-679.
20. Douglas, C. M., Foor, F., Marrinan, J. A. & 11 other authors (1994). The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-β-D-glucan synthase. Proc Natl Acad Sci USA 91, 12907-12911.
21. Fehr, T., Sanglier, J. J., Schuler, W., Gschwind, L., Ponelle, M., Schilling, W. & Wioland, C. (1996). Antascomicins A, B, C, D and E. Novel FKBP12 binding compounds from a Micromonospora strain. J Antibiot 49, 230-233.
22. Fields, S. & Song, O.-K. (1989). A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
23. Foor, F., Parent, S. A., Morin, N., Dahl, A. M., Ramadan, N., Chrebet, G., Bostian, K. A. & Nielsen, J. B. (1992). Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from α-factor arrest in yeast. Nature 360, 682-684.
24. Hatanaka, H., Iwami, M., Kino, T., Goto, T. & Okuhara, M. (1988a). FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. I. Taxonomy of the producing strain. J Antibiot 41, 1586-1591.
25. Hatanaka, H., Kino, T., Miyata, S., Inamura, N., Kuroda, A., Goto, T., Tanaka, H. & Okuhara. M. (1988b). FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics. J Antibiot 41, 1592-1601.
26. Heitman, J., Movva, N. R. & Hall, M. N. (1991a). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909.
27. Heitman, J., Movva, N. R., Hiestand, P. C. & Hall, M. N. (1991b). FK506-binding protein proline rotamase is a target for the immunosuppressive agent FK506 in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 88, 1948-1952.
28. Heitman, J., Movva, N. R. & Hall, M. N. (1992). Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression. New Biol 4, 448-460.
29. Helliwell, S. B., Wagner, P., Kunz, J., Deuter-Reinhard, M., Henriquez, R. & Hall, M. N. (1994). TORI and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol Biol Cell 5, 105-118.
30. +-ATPase assembly. Genetics 141, 833-844.
31. High, K. P. (1994). The antimicrobial activities of cyclosporine, FK506, and rapamycin. Transplantation 57, 1689-1700.
32. James, P., Halladay, J. & Craig, E. A. (1996). Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144, 1425-1436.
33. Katz, L. (1997). Manipulation of modular polyketide synthase. Chem Rev 97, 2557-2575.
34. Khaw, L. E., Böhm, G. A., Metcalfe, S., Staunton, J. & Leadlay, P. F. (1998). Mutational biosynthesis of novel rapamycins by a strain of Streptomyces hygroscopicus NRRL 5491 disrupted in rapL, encoding a putative lysine cyclodeaminase. J Bacteriol 180, 809-814.
35. Kino, T., Hatanaka, H., Miyata, S. & 8 other authors (1987). FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot 40, 1256-1265.
36. 1 progression. Cell 73, 585-596.
37. Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I. & Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
38. Lomovskaya, N., Fonstein, L., Ruan, X., Stassi, D., Katz, L. & Hutchinson, C. R. (1997). Gene disruption and replacement in the rapamycin-producing Streptomyces hygroscopicus strain ATCC 29253. Microbiology 143, 875-883.
39. Lorenz, M. C. & Heitman, J. (1995). TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J Biol Chem 270, 27531-27537.
40. Luengo, J. I., Yamashita, D. S., Dunnington, D. & 18 other authors (1995). Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface. Chem Biol 2, 471-481.
41. McCabe, R. E., Luft, B. J. & Remington, J. S. (1986). The effects of cyclosporine on Toxoplasma gondii in vivo and in vitro. Transplantation 41, 611-615.
42. Molnár, I., Aparicio, J. F., Haydock, S. F., Khaw, L. E., Schwecke, T., König, A., Staunton, J. & Leadlay, P. F. (1996). Organisation of the biosynthetic gene cluster for rapamycin in Streptomyces hygroscopicus : analysis of genes flanking the polyketide synthase. Gene 169, 1-7.
43. Moore, T. D. E. & Edman, J. C. (1993). The α-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene. Mol Cell Biol 13, 1962-1970.
44. Morisaki, M. & Arai, T. (1992). Identity of immunosuppressant FR-900520 with ascomycin. J Antibiot 45, 126-128.
45. Motamedi, H., Shafiee, A., Cai, S.-J., Streicher, S. L., Arison, B. H. & Miller, R. R. (1996). Characterization of methyltransferase and hydroxylase genes involved in the biosynthesis of the immunosuppressants FK506 and FK520. J Bacteriol 178, 5243-5248.
46. Motamedi, H., Cai, S.-J., Shafiee, A. & Elliston, K. O. (1997). Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506. Eur J Biochem 244, 74-79.
47. Nielsen, J. B., Hsu, M.-J., Byrne, K. M. & Kaplan, L. (1991). Biosynthesis of the immunosuppressant immunomycin: the enzymology of pipecolate incorporation. Biochemistry 30, 5789-5796.
48. Nishida, H., Sakakibara, T., Aoki, F. & 9 other authors (1995). Generation of novel rapamycin structures by microbial manipulations. J Antibiot 48, 657-666.
49. Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J. & Heitman, J. (1997a). Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 16, 2576-2589.
50. Odom, A., Poeta, M. D., Perfect J. & Heitman, J. (1997b). The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother 41, 156-161.
51. Pahl, A. & Keller, U. (1992). FK-506-binding proteins from Streptomycetes producing immunosuppressive macrolactones of the FK-506 type. J Bacteriol 174, 5888-5894.
52. Parent S. A., Nielsen, J. B., Morin, N., Chrebet, G., Ramadan, N., Dahl, A. M., Hsu, M.-J., Bostian, K. A. & Poor, F. (1993). Calcineurin-dependent growth of an FK506- and CsA-hypersensitive mutant of Saccharomyces cerevisiae. J Gen Microbiol 139, 2973-2984.
53. Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S. H. (1994). RAFT1 : a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35-43.
54. Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht G. & Abraham, R. T. (1995). Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 270, 815-822.
55. Salituro, G. M., Zink, D. L., Dahl, A., Nielsen, J., Wu, E., Huang, L., Kastner, C. & Dumont F. J. (1995). Meridamycin: a novel nonimmunosuppressive FKBP12 ligand from Streptomyces hygroscopicus. Tetrahedron Lett 36, 997-1000.
56. Schreiber, S. L. & Crabtree, G. R. (1992). The mechanism of action of cyclosporin A and FK506. Immunol Today 13, 136-142.
57. Schwecke, T., Aparicio, J. F., Molnár & 10 other authors (1995). The biosynthetic gene cluster for the polyketide immunosuppressant rapamycin. Proc Natl Acad Sci USA 92, 7839-7843.
58. Sehgal, S. N., Baker, H. & Vezina, C. (1975). Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot 28, 727-732.
59. Sherman, F. (1991). Getting started with yeast. Methods Enzymol 194, 3-21.
60. Singh, K., Sun, S. & Vezina, C (1979). Rapamycin (AY-22,989), a new antifungal antibiotic. IV. Mechanism of action. J Antibiot XXXII, 630-645.
61. Tropschug, M., Barthelmess, I. B. & Neupert W. (1989). Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae. Nature 342, 953-955.
62. Vezina, C., Kudelski, A. & Sehgal, S. N. (1975). Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing Streptomycete and isolation of the active principle. J Antibiot 28, 721-726.
63. Weisman, R., Choder, M. & Koltin, Y. (1997). Rapamycin specifically interferes with the developmental response of fission yeast to starvation. J Bacteriol 179, 6325-6334.
64. Wong, G. K., Griffith, S., Kojima, I. & Demain, A. L. (1998). Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and 32-desmethoxyrapamycin. J Antibiot 51, 487-491.
65. Zheng, X.-F., Florentino, D., Chen, J., Crabtree, G. R. & Schreiber, S. L. (1995). TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82, 121-130.